Drug Profile
Aranidipine
Alternative Names: Bec; MPC 1304; SaprestaLatest Information Update: 08 May 1997
Price :
$50
*
At a glance
- Originator Maruko Seiyaku
- Developer Maruko Seiyaku; Taiho Pharmaceutical
- Class Antihypertensives; Dihydropyridines
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Angina pectoris; Hypertension
Most Recent Events
- 08 May 1997 Launched for Hypertension in Japan (PO)
- 22 Jan 1996 Registered for Angina pectoris in Japan (PO)
- 22 Jan 1996 Registered for Hypertension in Japan (PO)